MedPath

Using 3D Imaging to Optimize Bifurcation Stenting

Phase 4
Conditions
Bifurcation Lesion
Coronary Artery Disease
Interventions
Device: Angio guidance arm
Device: 3D OFDI guidance arm
Registration Number
NCT02972489
Lead Sponsor
Increase Co., Ltd.
Brief Summary

The primary purpose of this study is to determine whether bifurcation stenting guided by on-line three-dimensional optical frequency domain imaging (3D-OFDI) is superior to that with angiographic guidance by measuring incomplete stent apposition (ISA) in the bifurcation segment.

Detailed Description

The recently developed optical frequency domain imaging (OFDI) can provide high quality resolution images of the coronary arteries. This new imaging system enhances the understanding of complex coronary lesions and the complex interaction between coronary devices and vessels by assembling/compiling 2-dimensional cross sections.

This 3-dimensional reconstruction with strut segmentation becomes possible on-line in the TERUMO OFDI console with 3-dimensional imaging software, which enables stent enhancement and 3D reconstruction within one minute. This "real time" 3D OFDI will promote the utilisation of 3-dimensional assessment in the treatment of bifurcation lesions.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
106
Inclusion Criteria
  1. Patient is at least 18 years of age and signed Informed Consent
  2. Subject has coronary artery disease involving a bifurcation with objective evidence of ischemia including patients with chronic stable angina, silent ischemia and non-ST segment elevation acute coronary syndrome (NSTE-ACS)
  3. Subject is appropriate to be treated by PCI according to the local practice (operator's judgment or heart team decision)
  4. Patients' residence is in the area covered by the hospital
  5. Patients with angiographically significant stenosis (>50 % by visual assessment) in de novo, native, previously unstented bifurcation lesion(s) including left main lesion, which is in operator's opinion appropriate to be treated by PCI with a single stent strategy
  6. The size of main vessel matches available Ultimaster stent sizes (<4.0 mm, and 2.0 mm by visual assessment)
  7. The size of side branch is >2.0mm in diameter by visual assessment
  8. The sidebranch is treatable with a sidebranch fenestration and/or kissing balloon
Exclusion Criteria
  1. Pregnancy
  2. Patients with ST elevation myocardial infarction
  3. Known intolerance to aspirin, clopidogrel, heparin, cobalt chromium, sirolimus, contrast material
  4. Known thrombocytopenia (platelet count< 100,000/mm3)
  5. Cardiogenic Shock
  6. Significant comorbidities precluding clinical follow-up (as judged by investigators)
  7. Major planned surgery that requires discontinuation of dual antiplatelet therapy
  8. History of stenting in the target bifurcation lesion
  9. Renal insufficiency (GFR/MDRD <45 ml/min), which precludes in operator's opinion contrast injection during repeat OFDI pullback
  10. Severely tortuous or angulated coronary anatomy of the study vessel that in the opinion of the investigator would result in sub-optimal optical frequency domain imaging (OFDI) or excessive risk of complication to place an OFDI catheter
  11. Target lesion reference vessel diameter (RVD) < 2.25 and > 4 mm
  12. Other: Patient is judged inappropriate by the attending physician

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Angio guidance armAngio guidance armBifurcation percutaneous coronary intervention (PCI) guided by angiography
3D OFDI guidance arm3D OFDI guidance armBifurcation percutaneous coronary intervention (PCI) optimized by online-3D OFDI during and after procedure
Primary Outcome Measures
NameTimeMethod
Percentage of malapposed strutsat time of bifurcation PCI surgery

Percentage of malapposed struts assessed by OFDI in bifurcation segment of main vessel

Secondary Outcome Measures
NameTimeMethod
Incomplete stent apposition (ISA) area (mm²)at time of bifurcation PCI surgery
Minimum lumen area (mm²)at time of bifurcation PCI surgery
Incidence of fulfilling optimal recrossing criteria on 3D-OFDIat time of bifurcation PCI surgery

Measured as a percentage

Mean stent area (mm²)at time of bifurcation PCI surgery
Maximum protrusion area (mm²)at time of bifurcation PCI surgery
Mean lumen area (mm²)at time of bifurcation PCI surgery
Minimum stent area (mm²)at time of bifurcation PCI surgery
Mean protrusion area (mm²)at time of bifurcation PCI surgery
Minimum flow area (mm²)at time of bifurcation PCI surgery
Mean flow area (mm²)at time of bifurcation PCI surgery

Trial Locations

Locations (2)

Fujita Health University

🇯🇵

Toyoake, Aichi Prefecture, Japan

Erasmus University Medical Center

🇳🇱

Rotterdam, South Holland, Netherlands

© Copyright 2025. All Rights Reserved by MedPath